-
公开(公告)号:EP2618665A4
公开(公告)日:2014-08-20
申请号:EP11827256
申请日:2011-09-16
发明人: MCCAULEY JOHN A , LIVERTON NIGEL J , RUDD MICHAEL T , GILBERT KEVIN F , FERRARA MARCO , SUMMA VINCENZO , CRESCENZI BENEDETTA
CPC分类号: A61K38/07 , A61K45/06 , C07D498/18 , C07K5/101 , C07K5/1016
-
公开(公告)号:EP2780026A4
公开(公告)日:2016-06-08
申请号:EP12850713
申请日:2012-11-09
发明人: RUDD MICHAEL T , MCCAULEY JOHN , LIVERTON NIGEL , GRISE-BARD CHRISTIANE , BROUCHU MARIE-CHRISTINE , CHARRON SYLVIE , AULAKH VIRENDER , BACHAND BENOIT , BEAULIEU PATRICK , ZAGHDANE HELMI , HAN YONGXIN , FERRARA MARCO , HARPER STEVEN , SUMMA VINCENZO , CHACKALAMANNIL SAMUEL , VENKATRAMAN SRIKANTH , SHAH UNMESH , VELAZQUEZ FRANCISCO
CPC分类号: C07K5/08 , A61K31/4745 , A61K31/5377 , A61K31/675 , A61K31/7056 , A61K38/005 , A61K38/06 , A61K38/12 , A61K38/21 , C07K5/0804 , C07K5/0808 , C07K5/0812 , C07K5/0821 , A61K2300/00
摘要: The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.
摘要翻译: 本发明涉及可用作丙型肝炎病毒(HCV)NS3蛋白酶抑制剂及其合成及其用于治疗或预防HCV感染的用途的式(I)的大环化合物。
-